CD4 and myeloid sarcoma: Consistent with observations of MS related disease, where MHC-II expressing OLCs could activate effector T-cells [35], we show that T-cells from a gut microbial depleted host could differentiate into IL17 CD4+ in presence of OLCs in vitro.